HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.67

EPS Forecast

$351.4

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics IncRVMDRevolution Medicines IncCRBUCaribou Biosciences Inc